查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832285

生物保存市場按產品類型、技術、樣品類型、應用和最終用戶分類－2025-2032 年全球預測

Biopreservation Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年生物防腐市場將成長 261.1 億美元，複合年成長率為 27.92%。

主要市場統計數據
基準年2024年 36.4億美元
預計2025年 46.7億美元
預測年份：2032年 261.1億美元
複合年成長率（%） 27.92%

生物保存已從實驗室的便利手段發展成為支持現代醫療服務、先進醫療手段和生命科學研究的關鍵任務能力。細胞和基因治療的進步、器官和組織庫計畫的不斷擴展以及複雜生技藥品的全球部署，共同推動了對生物材料可靠長期保存的商業需求。同時，低溫技術、保存化學和數位監控技術的進步使得可靠的保存在技術上可行，但也帶來了採購、法規遵循和人員能力方面的挑戰。

事實上，組織面臨著多方面的挑戰，包括將各種儲存技術整合到端到端工作流程中、管理專用耗材和設備的庫存，以及透過日益國際化的供應路線來維護低溫運輸的完整性。這些壓力與改善病患治療效果、減少浪費和擴展臨床服務的機會並存。因此，領導者必須在短期營運選擇與實現可擴展儲存能力的策略性投資之間取得平衡，同時確保其管治框架符合不斷變化的監管和認證要求。

本引言提供了高階主管層面的總結，探討了技術拐點、政策促進因素、商業性壓力以及機構可以採取的強化其保存策略的實際步驟。本文強調，臨床團隊、供應鏈經理和研發團隊之間需要跨職能協作，將保存科學轉化為可靠且可重複的實踐。最終，協作方式將決定哪些機構能夠持續支持下一代療法、擴大捐贈項目，並降低與供應中斷和合規性差距相關的風險。

生物保存技術、監管期望和商業化路徑的變革將重新定義生物樣本的儲存和使用方式。

在技​​術進步、監管趨嚴和商業化模式不斷發展的推動下，生物保存領域正在經歷一場變革。玻璃化冷凍和先進的冷凍乾燥技術等新型保存方法正在挑戰傳統的低溫運輸模式，而即時監控和物聯網支援的保存系統則提升了人們對資料連續性和可追溯性的期望。這些技術創新並非憑空而來；它們正在重塑企業設計儲存設施、培養人才以及協商供應商關係的方式。

同時，世界各地的監管機構正在加強對生物製藥處理、儲存檢驗和保管鏈文件的審查。這促使人們從臨時的實驗室級實踐轉向正式的品管體系，其中包括校準方案、通訊協定監測和記錄在案的緊急時應對計畫。隨著細胞和基因療法從臨床試驗階段轉向更廣泛的商業化，對可擴展、檢驗的儲存解決方案的需求正在加速成長。為此，耗材和儀器製造商正在提供模組化、可互通的產品，以減少整合摩擦並縮短檢驗時間。

這種轉變既帶來了複雜性，也帶來了機會。積極採用互操作系統、實施強大的數位可追溯性、並使採購符合監管要求的機構將降低營運風險並加快治療速度。相反，行動遲緩的機構則面臨腐敗加劇、審核缺陷增加以及新治療方法取得管道受限的風險。簡而言之，醫療格局正在從單點產品轉向需要跨職能協調和策略性投資的系統導向解決方案。

2025年美國關稅對生物保存供應鏈、試劑採購、設備採購及跨境臨床物流的累積影響

2025年實施的關稅變化為全球生物保存供應鏈帶來了新的複雜性，影響了關鍵試劑、特殊耗材和高價值設備的採購經濟效益。隨著各機構重新評估其供應商組合、規劃庫存緩衝，並評估進口和本地採購方案的總合到岸成本，其累積影響在整個採購週期中顯而易見。對一些機構而言，關稅環境加速了關於如何配置生產基地、建立區域配送中心以及優先實施多採購策略以增強韌性的討論。

在營運方面，設備和消耗品進口關稅的上漲延長了採購前置作業時間，並增加了設備升級的資本支出。採購和財務主管的應對措施包括與供應商重新談判契約，尋求包含價格保護條款的長期採購協議，並評估租賃和服務模式以減輕前期投資負擔。對於供應商而言，關稅正在推動其做出策略決策，例如本地組裝、擴大經銷商網路以及將投資重點放在需求充足且穩定的市場。

在臨床方面，關稅可能會透過改變先進療法和專業儲存工作流程的經濟效益，間接影響藥品的可近性，促使醫療保健系統優先考慮那些儲存成本能夠透過臨床價值得到合理證明的干涉措施。從風險角度來看，醫療保健機構現在需要在其應急計劃中考慮關稅波動，對其供應商生態系統進行壓力測試，並保持文件透明，以支持海關和監管機構的詢問。在這種環境下，策略性採購、嚴格的供應商資格審查和靈活的物流規劃是業務永續營運的關鍵要素。

將產品類型、儲存技術、樣本類別、應用程式和最終用戶動態與策略採用模式連結起來的關鍵細分洞察

要了解生物保存領域，需要綜合考慮產品類型、保存技術、樣本類別、臨床和研究應用以及最終用戶行為。從產品角度來看，生物保存領域分為耗材與設備兩大類。耗材包括冷凍保護劑、培養基、管瓶及冷凍試管。在冷凍保護劑中，二甲基亞碸(DMSO) 和甘油在細胞和組織實驗中仍然占主導地位，每種保護劑的選擇取決於其相容性和下游應用需求。設備組合涵蓋超低溫冷凍櫃、監控系統和儲存系統，其選擇取決於通量需求、預期驗證以及與設施環境控制的整合。

技術的選擇決定了操作設計。低溫保存、低溫儲存、冷凍乾燥和玻璃化冷凍在複雜性、穩定性和對不同生物樣本的適用性方面各有優劣。雖然低溫保存和低溫儲存通常用於細胞和血液成分，但冷凍乾燥和玻璃化冷凍擴大被考慮用於特殊組織產品和某些生物體液，因為這些產品的常溫穩定性和減少對低溫運輸的依賴性是其優勢。每種技術的選擇都會對後續的培訓、驗證和品質監控產生影響。

樣本類型的考慮可以進一步最佳化採購和營運優先順序。生物體液、血液成分、細胞、器官和組織在處理、控制和效價保存方面都有獨特的要求，這些要求會影響耗材的選擇和設備的尺寸。從輔助生殖和血庫到細胞療法、器官保存和組織工程等各種應用，都對產品和技術提出了特定的性能要求。最後，最終用戶（包括血庫、生育診所、醫院和診所、製藥和生物技術公司以及研究機構）的規模、監管嚴格程度和預算限制各不相同，這反過來又決定了他們的採用路徑和供應商選擇標準。整合這些細分視角，決策者能夠將技術投資與實際工作流程、監管要求和策略重點結合。

美洲、歐洲、中東和非洲以及亞太地區的區域動態和策略考量推動招聘、投資和政策協調

美洲、歐洲、中東和非洲以及亞太地區的區域動態顯著影響著生物保存的優先事項、投資模式和監管互動。在美洲，成熟的臨床基礎設施、不斷擴展的細胞和基因治療產品線以及整合的商業管道推動了對高通量低溫設備和經過驗證的耗材的需求，而法律規範則強調可追溯性和品質系統。這創造了一個環境，​​使得能夠提供快速驗證支援的規模化解決方案和服務模式對機構投資者尤其具有吸引力。

在歐洲、中東和非洲，嚴格的監管要求與多樣化的醫療保健服務模式相互作用，導致醫療服務採用格局差異化。嚴格監管的地區優先考慮經過認證的系統、詳盡的文件記錄以及與現有品管系統的互通性，而基礎設施受限的市場則可能更傾向於降低低溫運輸複雜性的解決方案，例如冷凍乾燥技術和簡化的儲存工作流程。為此，供應商通常會尋求針對特定地區的驗證方案，並與當地經銷商合作，以應對多樣化的採購和合規環境。

亞太地區的需求正在快速成長，這得益於生物技術研發投資的增加、生產能力的提升以及政府對先進療法的支持。該地區的多樣性意味著一些市場正在迅速採用尖端儲存技術，而其他市場則優先考慮本地生產和具成本效益的耗材。在整個地區，跨境監管協調努力和供應鏈本地化的趨勢正在塑造供應商策略，鼓勵建立夥伴關係夥伴關係、區域倉儲和客製化服務，以滿足司法管轄區的要求並縮短前置作業時間。

策略公司層面的洞察，重點在於競爭格局、夥伴關係、產品系列、製造地和創新管道

生物保存公司擴大將產品創新、垂直整合和服務產品相結合，以在充滿技術挑戰的環境中脫穎而出。領先的公司正在尋求端到端解決方案，將耗材、檢驗的儀器和數據豐富的監測平台相結合，以減輕臨床和研究客戶的整合負擔。耗材製造商和儀器供應商之間的策略夥伴關係日益普遍，從而實現了簡化驗證和採購的捆綁解決方案。

製造商正在投資模組化設計和互通性標準，以簡化與設施管理系統的整合，並支援遠端監控和預測性維護。同時，契約製造製造商和專業物流供應商正在擴展其能力，以提供區域組裝、最後低溫運輸冷鏈服務和受監管的倉儲中心。這些措施旨在縮短前置作業時間，並降低買家在管理跨地域的多家供應商時面臨的營運複雜性。

此外，各公司正透過將驗證支援、文件包和培訓服務納入其商業流程，使其產品藍圖與監管趨勢保持一致。這種方法使客戶能夠在履行合規義務的同時加快採用。他們的智慧財產權策略、旨在填補產品組合缺口的定向併購以及對生產冗餘的投資，也反映出他們對供應連續性和可靠地服務臨床和研究領域的能力的重視。

為產業領導者提供切實可行的建議，以加速復原能力、降低供應鏈風險並在治療、臨床和研究領域中獲得價值

產業領導者應採取一系列綜合行動，增強韌性，釋放價值，並支援維護解決方案的可擴展部署。首先，協調採購和臨床相關人員，制定統一的規範，優先考慮互通性、資料完整性和檢驗的便利性。這將減少產品認證過程中的摩擦，並縮短部署時間。其次，實現供應商網路多元化，納入能夠提供本地組裝、驗證支援和快速物流的區域合作夥伴和服務供應商，減少跨境關稅波動和運輸中斷帶來的風險。

第三，投資數位監控和預測性維護，以提高運轉率並實現主動品管。這些投資支持監管文件，並降低可能危及生物材料的溫度超調的可能性。第四，如果擔心資金限制或關稅導致的成本上升，請考慮租賃安排、託管服務或耗材捆綁，並建立商業合約以平衡資本和營運支出。第五，將培訓和變更管理納入部署，以確保員工能力與技術的複雜性和檢驗義務相符。

最後，納入基於情境的應急計劃，明確模擬關稅、供應商故障模式、緊急運輸路線等因素的影響。當供應鏈壓力因素出現時，這就能夠更快、更基於證據地做出決策。全面檢視這些行動，有助於組織從被動管理轉向對維護能力進行策略性管理。

透明的調查方法，概述資料來源、檢驗通訊協定、專家參與和分析框架，以確保情報的可靠性

本研究綜合基於多資訊來源方法，強調主要專家的參與、查閱技術文獻和檢驗供應商文件。主要輸入包括與臨床和供應鏈負責人進行結構化訪談、與設備和耗材製造商進行技術簡報，以及與法規事務專家進行磋商，以確保對合規性要求進行切實可行的解讀。這些定性見解與技術標準、產品規格和已發布的方法驗證指南相互參照，以驗證操作和性能聲明的準確性。

分析通訊協定強調可追溯性和可重複性。產品功能和操作方法的聲明均已根據製造商技術說明書、同行評審方案（如有）和記錄範例檢驗。專家評審員提供了關於採用障礙、培訓需求和檢驗時間表的背景資訊，為建議和風險評估提供了依據。我們實施了資料清理，以確保輸入資料是最新的，如果未經獨立檢驗，則專有資料或供應商提供的效能資料將被標記並視為有條件資料。

完整的交付成果明確闡述了研究的局限性和注意事項，包括尚未出現實證證據的領域以及不同地區監管解釋存在差異的領域。調查方法在技術深度和實際操作適用性之間取得平衡，使決策者能夠應用研究見解，同時也認知到需要進一步進行局部檢驗和前導測試的領域。

結論概述了臨床、商業和研究生態系統相關人員的策略要點、新興風險和近期優先事項

總而言之，生物保存領域處於科學創新、操作嚴謹性和供應鏈複雜性的交會點。保存化學和技術的進步為擴大臨床計畫和實現先進療法創造了新的機遇，而監管和商業性壓力正在重塑採購和檢驗的優先事項。這些因素的綜合作用促使人們轉向強調互通性、資料連續性和彈性採購的整合解決方案。

積極調整籌資策略、投資數位監控並協調跨職能相關人員的組織最有可能實現現代保存技術的臨床和營運效益。相反，延遲策略升級的公司則面臨浪費增加、臨床能力受限以及難以滿足監管要求的風險。因此，當務之急應著重於供應商多元化、有針對性地配置資本以實現互通性，以及將培訓和檢驗實踐制度化。

總體而言，務實、系統導向的方法，在技術應用與嚴格的品質管治之間取得平衡，將使醫療保健提供者、研究機構和商業開發商能夠將保護科學轉化為可靠的營運能力。相關人員應將本文提供的見解作為有針對性的測試、採購決策和政策參與的基礎。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 引入自動化低溫保存系統，提高細胞治療製造的可重複性和產量
  • 開發新型冰重結晶抑制劑以提高長期儲存期間生技藥品的活力
  • 在輔助生殖技術中採用玻璃化冷凍通訊協定來提高胚胎和卵子的存活率
  • 整合永續的冷凍保存技術，以降低生物銀行的成本和環境影響
  • 溫度敏感疫苗冷凍乾燥技術的進步延長了保存期限，無需依賴低溫運輸
  • 監管協調努力，以標準化全球生物保存工作流程和材料品管標準

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章 生物保存市場（依產品類型）

  • 耗材
    • 冷凍保護劑
      • DMSO
      • 甘油
    • 媒體
    • 管瓶和試管
  • 裝置
    • 低溫冷凍庫
    • 監控系統
    • 儲存系統

第9章 生物保存市場（按技術）

  • 冷凍保存
  • 冷藏
  • 冷凍乾燥
  • 玻璃化冷凍

第 10 章。按樣品類型分類的生物保存市場

  • 體液
  • 血液成分
  • 細胞
  • 器官
  • 組織

第11章按應用分類的生物保存市場

  • 輔助生殖技術
  • 血液保存
  • 細胞療法
  • 器官保存
  • 組織工程

第 12 章 生物保存市場（依最終使用者）

  • 血庫
  • 不孕不育診所
  • 醫院和診所
  • 製藥和生物技術公司
  • 研究機構

第 13 章按地區分類的生物保存市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章生物保存市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。各國生物保存市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • BioLife Solutions, Inc.
    • Azenta, Inc.
    • Cryoport, Inc.
    • Avantor, Inc.
    • Brooks Automation, Inc.
    • Lonza Group AG
    • Sartorius AG
Product Code: MRR-437D45957B50

The Biopreservation Market is projected to grow by USD 26.11 billion at a CAGR of 27.92% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.64 billion
Estimated Year [2025] USD 4.67 billion
Forecast Year [2032] USD 26.11 billion
CAGR (%) 27.92%

Biopreservation has evolved from a laboratory convenience to a mission-critical capability underpinning modern healthcare delivery, advanced therapeutics, and life sciences research. Advances in cell and gene therapies, expanded organ and tissue banking initiatives, and the global roll-out of complex biologics have together increased the operational imperative to preserve biological materials reliably over extended periods. Concurrently, improvements in cryogenic engineering, preservation chemistries, and digital monitoring have made high-integrity storage more technically achievable, yet have also raised the bar for procurement, regulatory compliance, and workforce competency.

In practice, organizations face a multifaceted set of challenges: integrating diverse preservation technologies into end-to-end workflows, managing specialized consumable and equipment inventories, and maintaining cold chain integrity across increasingly international supply routes. These pressures coexist with opportunities to enhance therapeutic outcomes, reduce waste, and extend the reach of clinical services. As a result, leaders must balance near-term operational choices with strategic investments that enable scalable preservation capabilities, while ensuring governance frameworks meet evolving regulatory and accreditation expectations.

This introduction sets the stage for an executive-level synthesis that examines technological inflection points, policy drivers, commercial pressures, and practical steps organizations can apply to fortify their preservation strategies. It underscores the need for cross-functional alignment among clinical teams, supply chain managers, and R&D groups to translate preservation science into reliable, reproducible practice. Ultimately, a coordinated approach will determine which institutions can sustainably support next-generation therapies, expand donor programs, and mitigate risks tied to supply disruptions and compliance gaps.

Transformative shifts in biopreservation technology, regulatory expectations, and commercialization pathways redefining how biological materials are preserved and mobilized

The landscape of biopreservation is undergoing transformative shifts driven by converging technological advances, regulatory intensification, and evolving commercialization models. Emerging preservation methods such as vitrification and refined lyophilization techniques are challenging legacy cold chain paradigms, while real-time monitoring and IoT-enabled storage systems are elevating expectations for data continuity and traceability. These innovations are not isolated; they are reshaping how organizations design storage facilities, train personnel, and negotiate supplier relationships.

At the same time, regulatory bodies worldwide are tightening oversight of biologic handling, storage validation, and chain-of-custody documentation. This has prompted a move from ad hoc, lab-level practices to formalized quality management systems encompassing calibration protocols, environmental monitoring, and documented contingency plans. Commercial pressures are also reshaping the market: as cell and gene therapies move from clinical trials into broader commercialization, the need for scalable, validated preservation solutions has accelerated. Manufacturers of consumables and equipment are responding with modular, interoperable offerings designed to reduce integration friction and shorten validation timelines.

These shifts create both complexity and opportunity. Organizations that proactively adopt interoperable systems, implement robust digital traceability, and align procurement with regulatory expectations can reduce operational risk and speed time-to-treatment. Conversely, institutions that lag in adoption risk increased spoilage, audit findings, and constrained access to emerging therapies. In short, the landscape is moving from discrete products toward systems-oriented solutions that require cross-functional coordination and strategic investment.

Cumulative impact of United States tariffs in 2025 on biopreservation supply chains, reagent sourcing, equipment procurement, and cross-border clinical logistics

Tariff changes implemented in 2025 introduced a new layer of complexity to global biopreservation supply chains, affecting the sourcing economics for critical reagents, specialized consumables, and high-value equipment. The cumulative effects are noticeable across procurement cycles as organizations reassess supplier portfolios, plan inventory buffers, and evaluate the total landed cost of imports versus regional sourcing options. For some institutions, the tariff environment has accelerated conversations about reshoring production, establishing regional distribution hubs, and prioritizing multi-sourcing strategies to strengthen resilience.

Operationally, increased import duties on equipment and consumables have translated into longer procurement lead times and higher capital outlays for facility upgrades. Procurement and finance leaders have responded by renegotiating supplier contracts, seeking longer-term purchase agreements that include price protection clauses, and evaluating leasing or service-based models to mitigate upfront capital burdens. For suppliers, tariffs have encouraged strategic decisions including local assembly, expanded distributor networks, and targeted investments in markets where demand is both material and stable.

Clinically, tariffs can indirectly affect access by shifting the economics of advanced therapies and specialized preservation workflows, prompting healthcare systems to prioritize interventions where preservation costs can be justified by clinical value. From a risk perspective, organizations must now account for tariff volatility in contingency planning, stress-test their supplier ecosystems, and maintain transparent documentation to support customs and regulatory inquiries. In this environment, strategic procurement, rigorous supplier qualification, and flexible logistics planning become essential components of operational continuity.

Key segmentation insights linking product types, preservation technologies, sample classes, applications, and end-user dynamics to strategic adoption patterns

Understanding the biopreservation landscape requires an integrated view of product typologies, preservation technologies, the array of sample classes, clinical and research applications, and end-user behaviors. From a product perspective, offerings split into consumables and equipment, with consumables encompassing cryoprotectants, media, and vials and tubes. Within cryoprotectants, dimethyl sulfoxide (DMSO) and glycerol remain dominant chemistries for cell and tissue work, each selected based on compatibility profiles and downstream application requirements. Equipment portfolios cover cryogenic freezers, monitoring systems, and storage systems, and their selection depends on throughput needs, validation expectations, and integration with facility environmental controls.

Technology choices shape operational design. Cryopreservation, hypothermic storage, lyophilization, and vitrification offer distinct trade-offs in complexity, stability, and suitability for different biological materials. Cryopreservation and hypothermic storage are commonly used for cells and blood components, while lyophilization and vitrification are increasingly considered for specialized tissue products and certain biological fluids where ambient stability or reduced cold chain dependence is advantageous. Each technology choice has downstream implications for training, validation, and quality oversight.

Sample type considerations further refine procurement and operational priorities. Biological fluids, blood components, cells, organs, and tissues present unique handling, containment, and potency-preservation requirements that inform both consumable selection and equipment sizing. Applications-ranging from assisted reproductive technology and blood preservation to cell therapy, organ preservation, and tissue engineering-drive specific performance attributes for products and technologies. Finally, end users such as blood banks, fertility clinics, hospitals and clinics, pharmaceutical and biotech companies, and research institutes differ in scale, regulatory rigor, and budgetary constraints, which in turn shape adoption pathways and supplier selection criteria. Integrating these segmentation lenses enables decision-makers to align technology investments with practical workflows, regulatory obligations, and strategic priorities.

Regional dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive adoption, investment, and policy alignment

Regional dynamics significantly influence biopreservation priorities, investment patterns, and regulatory interactions across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, established clinical infrastructure, expanding cell and gene therapy pipelines, and integrated commercial channels drive demand for high-throughput cryogenic equipment and validated consumables, while regulatory frameworks emphasize traceability and quality systems. This creates an environment where scaled solutions and service models that offer rapid validation support are particularly attractive to institutional buyers.

Across Europe, Middle East & Africa, the interplay between stringent regulatory expectations and diverse healthcare delivery models results in a heterogeneous adoption landscape. High-regulation jurisdictions prioritize certified systems, thorough documentation, and interoperability with existing quality management systems, whereas markets with constrained infrastructure may favor solutions that reduce cold chain complexity, such as lyophilization or simplified storage workflows. In response, suppliers often pursue region-specific validation packages and collaborate with local distributors to navigate varied procurement and compliance environments.

Asia-Pacific presents a fast-growing demand profile driven by rising investments in biotech R&D, expanding manufacturing capabilities, and government support for advanced therapies. The diversity of the region means that some markets rapidly adopt cutting-edge preservation technologies, while others place emphasis on localized manufacturing and cost-effective consumables. Across all regions, cross-border regulatory harmonization efforts and supply chain localization trends shape supplier strategies, prompting partnerships, regional warehousing, and tailored service offerings to meet jurisdictional requirements and reduce lead times.

Competitive landscape and strategic company-level insights focusing on partnerships, product portfolios, manufacturing footprints, and innovation pipelines

Company strategies in the biopreservation space increasingly combine product innovation, vertical integration, and service-enabled offerings to differentiate in a technically demanding environment. Leading organizations pursue end-to-end solutions that integrate consumables, validated equipment, and data-rich monitoring platforms, thereby reducing the integration burden for clinical and research customers. Strategic partnerships between consumable manufacturers and equipment providers are becoming more common, enabling bundled solutions that simplify validation and procurement.

Manufacturers are investing in modular designs and interoperability standards to ease integration with facility management systems and to support remote monitoring and predictive maintenance. In parallel, contract manufacturers and specialized logistics providers are expanding capabilities to offer regional assembly, cold-chain last-mile services, and regulated storage hubs. These moves aim to shorten lead times and reduce the operational complexity that buyers face when managing multiple vendors across disparate geographies.

Additionally, companies are aligning product roadmaps with regulatory trends by embedding validation support, documentation packages, and training services into their commercial offerings. This approach helps customers accelerate implementation while meeting compliance obligations. Intellectual property strategies, targeted M&A to fill portfolio gaps, and investments in manufacturing redundancy are also evident, reflecting a prioritization of supply continuity and the ability to serve both clinical and research segments reliably.

Actionable recommendations for industry leaders to accelerate resilience, de-risk supply chains, and capture value across therapeutic, clinical, and research segments

Industry leaders should adopt an integrated set of actions that strengthen resilience, unlock value, and support scalable deployment of preservation solutions. First, align procurement and clinical stakeholders to create unified specifications that prioritize interoperability, data integrity, and ease of validation. Doing so reduces friction during product qualification and shortens implementation timelines. Second, diversify supplier networks to include regional partners and service providers capable of local assembly, validation support, and responsive logistics, thereby reducing exposure to cross-border tariff volatility and shipping disruptions.

Third, invest in digital monitoring and predictive maintenance to improve uptime and enable proactive quality management. These investments support regulatory documentation and reduce the likelihood of temperature excursions that can compromise biological materials. Fourth, structure commercial agreements to balance capital and operational expenditures; explore leasing, managed services, or bundled consumable agreements when capital constraints or tariff-driven cost increases are a concern. Fifth, embed training and change management into rollouts to ensure that staff competencies keep pace with technological complexity and validation obligations.

Finally, incorporate scenario-based contingency planning that explicitly models tariff impacts, supplier failure modes, and emergency transport routes. This will enable faster, evidence-based decisions when supply chain stressors materialize. Collectively, these actions will help organizations transition from reactive management to strategic stewardship of their preservation capabilities.

Transparent research methodology outlining data sources, validation protocols, expert engagements, and analytical frameworks used to ensure robust intelligence

This research synthesis is built on a multi-source methodology that emphasizes primary expert engagement, curated technical literature, and validated supplier documentation. Primary inputs included structured interviews with clinical and supply chain leaders, technical briefings with equipment and consumable manufacturers, and consultations with regulatory affairs specialists to ensure practical interpretation of compliance requirements. These qualitative insights were cross-referenced with technical standards, product specifications, and published method validation guidance to triangulate operational and performance claims.

Analytical protocols emphasized traceability and reproducibility. Claims about product capabilities and operational practices were validated against manufacturer technical sheets, peer-reviewed protocols where available, and documented real-world case examples. Expert reviewers provided context on adoption barriers, training needs, and validation timelines, which informed the recommendations and risk assessments. Data hygiene practices were applied to ensure that inputs were current, and any proprietary or vendor-supplied performance data were labeled and treated as conditional when not independently verified.

Limitations and caveats are clearly stated within the full deliverable, including areas where empirical evidence remains emergent or where regional regulatory interpretations diverge. The methodology balances depth of technical understanding with practical operational applicability, enabling decision-makers to apply the insights while acknowledging areas that warrant further localized validation or pilot testing.

Conclusion synthesizing strategic takeaways, emergent risks, and near-term priorities for stakeholders across clinical, commercial, and research ecosystems

In conclusion, the biopreservation domain sits at the intersection of scientific innovation, operational rigor, and supply chain complexity. Advances in preservation chemistries and storage technologies are creating new opportunities to expand clinical programs and enable advanced therapies, while regulatory and commercial pressures are reshaping procurement and validation priorities. The combined effect is a shift toward integrated solutions that emphasize interoperability, data continuity, and resilient sourcing.

Organizations that proactively recalibrate procurement strategies, invest in digital monitoring, and align cross-functional stakeholders will be best positioned to realize the clinical and operational benefits of modern preservation techniques. Conversely, those that defer strategic upgrades risk increased wastage, constrained clinical capacity, and difficulties meeting regulatory expectations. Near-term priorities should therefore focus on supplier diversification, targeted capital allocation for interoperability, and institutionalizing training and validation practices.

Overall, a pragmatic, systems-oriented approach that balances technology adoption with rigorous quality governance will enable healthcare providers, research organizations, and commercial developers to convert preservation science into dependable operational capability. Stakeholders should treat the insights provided here as a foundation for targeted pilots, procurement decisions, and policy engagement that together will shape the reliability and scalability of biopreservation services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of automated cryopreservation systems to improve reproducibility and throughput in cell therapy manufacturing
  • 5.2. Development of novel ice recrystallization inhibitors for enhanced viability of preserved biologics during long-term storage
  • 5.3. Adoption of vitrification protocols in assisted reproductive technology to boost embryo and oocyte survival rates
  • 5.4. Integration of sustainable cryogen-free preservation technologies to reduce costs and environmental impact in biobanking
  • 5.5. Advances in lyophilization techniques for temperature-sensitive vaccines to extend shelf life without cold chain dependency
  • 5.6. Regulatory harmonization efforts to standardize quality control criteria for global biopreservation workflows and materials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopreservation Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Cryoprotectants
      • 8.1.1.1. DMSO
      • 8.1.1.2. Glycerol
    • 8.1.2. Media
    • 8.1.3. Vials & Tubes
  • 8.2. Equipment
    • 8.2.1. Cryogenic Freezers
    • 8.2.2. Monitoring Systems
    • 8.2.3. Storage Systems

9. Biopreservation Market, by Technology

  • 9.1. Cryopreservation
  • 9.2. Hypothermic Storage
  • 9.3. Lyophilization
  • 9.4. Vitrification

10. Biopreservation Market, by Sample Type

  • 10.1. Biological Fluids
  • 10.2. Blood Components
  • 10.3. Cells
  • 10.4. Organs
  • 10.5. Tissues

11. Biopreservation Market, by Application

  • 11.1. Assisted Reproductive Technology
  • 11.2. Blood Preservation
  • 11.3. Cell Therapy
  • 11.4. Organ Preservation
  • 11.5. Tissue Engineering

12. Biopreservation Market, by End User

  • 12.1. Blood Banks
  • 12.2. Fertility Clinics
  • 12.3. Hospitals & Clinics
  • 12.4. Pharmaceutical & Biotech Companies
  • 12.5. Research Institutes

13. Biopreservation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biopreservation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biopreservation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. Merck KGaA
    • 16.3.4. BioLife Solutions, Inc.
    • 16.3.5. Azenta, Inc.
    • 16.3.6. Cryoport, Inc.
    • 16.3.7. Avantor, Inc.
    • 16.3.8. Brooks Automation, Inc.
    • 16.3.9. Lonza Group AG
    • 16.3.10. Sartorius AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPRESERVATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPRESERVATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIOPRESERVATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIOPRESERVATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIOPRESERVATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPRESERVATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPRESERVATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPRESERVATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPRESERVATION MARKET SIZE, BY DMSO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPRESERVATION MARKET SIZE, BY GLYCEROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPRESERVATION MARKET SIZE, BY MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPRESERVATION MARKET SIZE, BY VIALS & TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPRESERVATION MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPRESERVATION MARKET SIZE, BY STORAGE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPRESERVATION MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPRESERVATION MARKET SIZE, BY HYPOTHERMIC STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPRESERVATION MARKET SIZE, BY LYOPHILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPRESERVATION MARKET SIZE, BY VITRIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPRESERVATION MARKET SIZE, BY BIOLOGICAL FLUIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOPRESERVATION MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD PRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOPRESERVATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOPRESERVATION MARKET SIZE, BY ORGAN PRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOPRESERVATION MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOPRESERVATION MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOPRESERVATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOPRESERVATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOPRESERVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOPRESERVATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOPRESERVATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOPRESERVATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY CRYOPROTECTANTS, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC BIOPRESERVATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. GLOBAL BIOPRE